Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention

Corona Virus Infection Clinical Trial

Official title:

Department of Chinese Medicine, Branch of Linsen, Chinese Medicine, and Kunming, Taipei City Hospital, Taipei, Taiwan Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04388644
• Other study ID #: TCHIRB-10904015-E
• Status: Recruiting
• Start date: February 20, 2020
• Est. completion date: May 30, 2020

Study information

• Verified date: February 2020
• Source: Taipei City Hospital
• Contact: Chung Hua Hsu, PhD
• Phone: 886-2-23887088
• Email: dap63[@]tpech.gov.tw
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

the retrospective observation study, the first line to care CAVID-19

Description:

The satisfaction of using nature herbal medicine for frontline medical staffs to prevent COVID-19: a retrospective clinical study.

The medical frontline staffs have the high risk to be infected during working. The stress and load were acuminated, especially when they got the similar symptoms as COVID-19. NHM has been used to early prevention for thousands of years9-12. It was well accept to take NHM for early prevention in many Asia-Pacific countries. Although many NHM remedies of COVID-19 treatment or prevention were reported, but the related study were lacking. To understand the pressure and the satisfaction of frontline medical staffs after taking JGF for early prevention we conducted this retrospective clinical study to explore the relationship in different groups.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: May 30, 2020
• Est. primary completion date: May 20, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 65 Years

Eligibility

Inclusion Criteria:

• The person first-line medical staff in hospital

• the inspection personnel in airport

• self-quarantine at home.

• self-quarantine at office.

Exclusion Criteria:

• no willing to participate

• allergy to herbal medicine

• severe illness evaluated by physician

Related Conditions & MeSH terms

• Corona Virus Infection
• Coronavirus Infections
• Severe Acute Respiratory Syndrome

Locations

Country	Name	City	State
Taiwan	Branch of Chinese Medicine, Taipei City Hospital	Taipei
Taiwan	Branch of Linsen Chinese Medicine and Kunming, Taipei City Hospital	Taipei
Taiwan	Taipei City Hospital	Taipei

Sponsors (2)

Lead Sponsor	Collaborator
Taipei City Hospital	National Yang Ming University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the number confirmed COVID-19 cases	The isolated person and first-line care person who taking JGF	8 weeks
Primary	The person with COVID-19 like symptoms	The isolated person and first-line care person who taking JGF	8 weeks
Secondary	The improving rate of COVID-19 like symptoms	The isolated person and first-line care person who taking JGF	8 weeks
Secondary	The satisfaction% to taking JGF	The isolated person and first-line care person who taking JGF	8 weeks